scholarly article | Q13442814 |
P356 | DOI | 10.1016/0041-0101(93)90129-7 |
P698 | PubMed publication ID | 8266346 |
P50 | author | José María Gutiérrez | Q42425503 |
P2093 | author name string | G Borkow | |
M Ovadia | |||
P433 | issue | 9 | |
P921 | main subject | Bothrops asper | Q384987 |
snake | Q2102 | ||
P304 | page(s) | 1137-1150 | |
P577 | publication date | 1993-09-01 | |
P1433 | published in | Toxicon | Q7830412 |
P1476 | title | Isolation and characterization of synergistic hemorrhagins from the venom of the snake Bothrops asper | |
P478 | volume | 31 |
Q41770422 | Bothrops asper snake venom and its metalloproteinase BaP-1 activate the complement system. Role in leucocyte recruitment. |
Q33352795 | Characterization of 'basparin A,' a prothrombin-activating metalloproteinase, from the venom of the snake Bothrops asper that inhibits platelet aggregation and induces defibrination and thrombosis |
Q59290807 | Characterization of the local tissue damage induced by LHF-II, a metalloproteinase with weak hemorrhagic activity isolated from Lachesis muta muta snake venom |
Q59290755 | Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper |
Q38779503 | Evaluating local adaptation of a complex phenotype: reciprocal tests of pigmy rattlesnake venoms on treefrog prey. |
Q59290877 | Immunoglobulin G and F(ab′)2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom |
Q64078667 | Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives |
Q47740289 | Inhibition of a snake venom hemorrhagic metalloproteinase by human and rat alpha-macroglobulins |
Q59290882 | Inhibition of the hemorrhagic activity of Bothrops asper venom by a novel neutralizing mixture |
Q60199594 | Inhibitory properties of the anti-bothropic complex from Didelphis albiventris serum on toxic and pharmacological actions of metalloproteases and myotoxins from bothrops asper venom 1 1Abbreviations: SVMPs, snake venom metalloproteases; ABC, anti-bot |
Q45383599 | Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper. |
Q50659374 | Pharmacological investigation of oedema induced by venom from the wasp Polistes fuscatus. |
Q43767683 | Purification and characterisation of two hemorrhagic metalloproteinases from the venom of the long-nosed viper, Vipera ammodytes ammodytes |
Q59290783 | Purification and characterization of BaH4, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper |
Q33626504 | Purification and characterization of a new weak hemorrhagic metalloproteinase BmHF-1 from Bothrops marajoensis snake venom. |
Q35951250 | Purification procedure for the isolation of a P-I metalloprotease and an acidic phospholipase A2 from Bothrops atrox snake venom. |
Q33538519 | Snake venom hemorrhagins |
Q28138228 | Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage |
Q58091896 | Systemic vascular leakage induced in mice by Russell's viper venom from Pakistan |
Q38209626 | The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi |
Q41996003 | The snake venom metalloproteinase BaP1 induces joint hypernociception through TNF-alpha and PGE2-dependent mechanisms |
Q26776282 | Understanding and confronting snakebite envenoming: The harvest of cooperation |